Lauren Biscaldi is the Managing Editor of Drug Topics, a publication focused on retail, community, and health systems pharmacy. With a background in pharmacy journalism, Lauren covers a wide range of topics including drug approvals, clinical updates, healthcare policies, and patient care. Her work has been featured in publications such as Patient Care, Psychiatric Times, and Dermatology Times.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Lauren's coverage predominantly focuses on healthcare and pharmaceutical topics, particularly medication-related issues. She relies heavily on data citations and government announcements in her articles.
To effectively reach out to Lauren, consider providing evidence-based insights into medication trends or developments within the healthcare industry. Experts who can provide data-driven analysis, especially related to pharmacy practices, medication access, or responses to public health crises such as the opioid epidemic or COVID-19 would likely be of interest to her.
As she does not have a specified geographic focus, pitches should appeal to an international audience and avoid localization unless it directly impacts broader industry trends.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Novavax is still awaiting FDA authorization for their protein-based COVID-19 vaccine.
Addressing the external factors that can have an impact on patient health can make clinical interventions more effective when administered.
Vials of tirzepatide 2.5 mg and 5 mg will be available at a 50% discount compared with the list price of other incretin-based obesity medications.
The device was previously cleared for use in children and adults with type 1 diabetes.
By: Lauren Biscaldi
The FDA has authorized BioVie’s investigational new drug application for the evaluation of bezisterim to treat neurological symptoms associated with post–COVID-19 condition.
The vaccine, VAX-31, targets 20 serotypes in common with PCV20, as well as 11 additional serotypes.
Additional data will be presented at a scientific meeting later this year.
By: Lauren Biscaldi
The #MyCRChistory campaign encourages the public to share their family history of colorectal cancer.
Data from the SELECT clinical trial were analyzed to evaluate the role of semaglutide therapy on all-cause, cardiovascular, and non-cardiovascular mortality during the COVID-19 pandemic.
By: Lauren Biscaldi
The “cuddle hormone” plays a powerful role in human behavior and may be an additional option to treat pain and manage opioid addiction.
(833) 317-6278 
